2,6 The Australian evidence-based clinical guidelines for diabetes recommend GLP-1RAs as an add-on therapy in patients with cardiovascular disease, multiple cardiovascular risk factors or kidney disease, and intolerance or a contraindication to sodium-glucose cotransporter 2 (SGLT-2) inhibitors
2023 Mar 30;388(13):1210-1218
31,32 Conversely, the inflammatory process, impaired lung function and/or the use of glucocorticoids in COPD patients may increase the risk of developing diabetes
Just because you didnt get sick by risky behavior one time, doesnt mean you will never get sick if you continue to disregard the rules
Yes, Aetna often covers Wegovy, but coverage varies by plan
However, Wegovy is a tool to support weight loss, not a magic solution